skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
Jul 13, 2018 2018 FC 736 Eli Lilly Canada Inc. et al v. Apotex Inc. We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.

Patents

Apr 10, 2018 Federal Court File Nos. T-598-17 through T-605-17 AbbVie Corporation et al v Samsung Bioepis Co. Ltd. We represented AbbVie in a series of eight applications under the Patented Medicines (Notice of Compliance) Regulations relating to AbbVie’s ...

Patents

Apr 9, 2018 Federal Court File No. T-1355-17 Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al. We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...

Patents

Jan 20, 2017 2016 FC 1361 Janssen Inc. et al. v. Actavis Pharma Company et al. We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA.  The generic company Actavis Pharma had challen...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We obtained damages in excess of $18M for Teva’s infringement of a patent covering Janssen’s LEVAQUIN product.

Patents

Sep 16, 2015 2015 FCA 192 Actavis Pharma Company v. Alcon Canada Inc. We successfully resisted Actavis’ appeal of the trial judge’s finding that the basic compound patent protecting VIGAMOX was valid.

Patents

Oct 28, 2014 2014 FCA 242 Janssen Inc. v. Abbvie Corporation We successfully represented Janssen on this appeal from a refusal to grant an amendment to Janssen’s pleading.  The Court of Appeal agre...

Patents

May 14, 2014 2014 FC 462 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company We successfully defended the validity of Bayer’s key patent covering the anti-infective moxifloxacin (AVELOX® and VIGAMOX ®) and obta...

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy